Skip to content

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

The Effect of Fermented Soybean Supplementation on the Body Weight and Physical Function of Tuberculosis Patients With Standard Therapy in Indonesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02554318
Acronym
FSS
Enrollment
147
Registered
2015-09-18
Start date
2013-11-30
Completion date
2015-02-28
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight Changes, Motor Activity, Pulmonary Tuberculosis

Keywords

Tempeh, Body weight, Handgrip strength, 6MWT, Supplementation, Wasting

Brief summary

Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.

Detailed description

This study was carried out at the outpatient department building, lung hospital Surabaya, Indonesia. As a national health referral system in TB program, the hospital was related to four local sub district health centers that were involved in the recruitment of participants in the study. Patients with newly diagnosed pulmonary tuberculosis were randomly assigned into two groups, namely intervention group, which consisted of 65 participants and control group which had 64 participants. Randomization was carried out using sealed, unmarked opaque envelopes that are allocated to participants in this study. A minimum sample size of per group (n=64) was determined by Windows version G\*Power 3.1.5 software to identify a mean difference in body weight change of ≥1.1 kg between intervention and control groups. The intervention group obtained the standard therapy of TB and an additional 166.5 grams of boiled tempeh daily for two months. The control group obtained only standard TB therapy. Patients in the intervention group were instructed to divide one cake tempeh into three pieces and eat them three times in a day. Consumption frequencies of supplements were recorded in a logbook by an enumerator during random visits once a week. One of the patient family members was asked to help to supervise compliance. The participants were assessed before and after the intervention period for both groups. Body weight of the participants was evaluated by measuring the change in body weight. The change of physical function was assessed by handgrip strength using a digital dynamometer and 6-minute walk test (6MWT). Protein and caloric intakes were estimated twice, measured during the first and second months using 24-hour dietary recall method during the intervention period.

Interventions

DRUGRifampicin
DRUGIsoniazid
DRUGPyrazinamide
DRUGEthambutol
DIETARY_SUPPLEMENTFermented soybean

Sponsors

Indonesian Directorate General of Higher Education
CollaboratorOTHER_GOV
University of Giessen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed adult male and female TB active patients * Having clinical evidences of active TB symptoms * Positive or negative sputum smears * Having positive chest X-ray that compatible with a diagnosis of tuberculosis * No history of previous anti tuberculosis treatment * Give a written informed consent and basic contact data

Exclusion criteria

* Heavy smoker (\> 20 cigarettes per day) * Pregnancy and lactation * Extra pulmonary TB * Known allergy to soybean * Having clinical evidences of any underlying disease

Design outcomes

Primary

MeasureTime frameDescription
Change in Bodyweight on a Digital Weight Scale From Baseline at 2 MonthsBaseline, 2 monthsChange of body weight of the participants over the two months intervention period as measured on a kilograms scale. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Positive numbers represent increases and negative numbers represent decreases. A higher value score in change means a better outcome on nutritional status for the patients after the study.

Secondary

MeasureTime frameDescription
Change in Hand-grip Strength on a Digital Dynamometer Scale From Baseline at 2 MonthsBaseline, 2 monthsThe change of hand-grip strength of the participants over the two months intervention period was measured on a kilograms scale. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Positive numbers represent increases and negative numbers represent decreases. The higher scores reflected the better physical function outcomes of the patients.
Change in Distance on 6-minute Walk Test (6MWT) From Baseline at 2 MonthsBaseline, 2 monthsThe change distance in meters scale as assessed by 6MWT according to American Thoracic Society (ATS) 2002 guidelines. The 6MWT was carried out on a track along the 30-meter corridor marked by two colored cones placed at both ends of the track alignment. The participants were asked using the standard instruction to walk at their self-selected pace back and forth between the cones as far as they could for 6 minutes. The distance taken by each participant was measured and then recorded. Instructions were given to every patient by reading a guideline with the same intonations to every patient before performing the test. The result of the 6MWT was expressed in meters. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Higher scores reflected better physical function outcomes.
Change in Body Mass Index (BMI) From Baseline at 2 MonthsBaseline, 2 monthsThe change in BMI was assessed by a digital weight scale and height scale (kg/m²). The formula for BMI is weight in kilograms divided by height in meters squared. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Higher scores reflected the better nutritional status results of the patients.

Other

MeasureTime frameDescription
Caloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.In the course of the 8 week intervention, two interviews were conducted; at the 2nd and 6th week.The average calorie intake (in kcal/day) was assessed by the 24-hour dietary recall questionnaire and calculated by NutriSurvey software version 2005, with the country-specific food database for Indonesia.
Protein Intake on 24-hour Dietary Recall Method.In the course of the 8 week intervention, two interviews were conducted; at the 2nd and 6th week.The average protein intake (in Gram/day) was assessed by the 24-hour dietary recall questionnaire and calculated using NutriSurvey software version 2005, with the country specific food database for Indonesia.

Participant flow

Recruitment details

Between November 2013 and February 2015, patients who attended the lung clinics in Surabaya for newly diagnosed pulmonary TB were screened for study enrollment.

Pre-assignment details

After the enrollment of the study, several participants withdrew their assignment due to several reasons such as underlying disease, heavy smoker, they did not stay in the city, plan to move to other city, and dislike the food.

Participants by arm

ArmCount
Intervention
TB standard therapy with fixed dose combination : once per day by mouth for 2 months Fixed dose combination = RHZE (150mg/75mg/400mg/275mg) R=rifampicin, H=isoniazid, Z=pyrazinamide, E=ethambutol, Patients with body weight: 30 - 37 kg = 2 tablets, 38 - 54 kg = 3 tablets, 55 - 70 kg = 4 tablets, and ≥71 kg = 5 tablets and 166.5 grams cooked fermented soybean (tempeh) daily for two months Rifampicin Isoniazid Pyrazinamide Ethambutol Fermented soybean
65
Control
TB standard therapy with fixed dose combination : once per day by mouth for 2 months Fixed dose combination = RHZE (150mg/75mg/400mg/275mg) R=rifampicin, H=isoniazid, Z=pyrazinamide, E=ethambutol, Patients with body weight: 30 - 37 kg = 2 tablets, 38 - 54 kg = 3 tablets, 55 - 70 kg = 4 tablets, and ≥71 kg = 5 tablets Rifampicin Isoniazid Pyrazinamide Ethambutol
64
Total129

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject108

Baseline characteristics

CharacteristicInterventionControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
65 Participants64 Participants129 Participants
Age, Continuous31.11 years
STANDARD_DEVIATION 9.63
34.45 years
STANDARD_DEVIATION 10.35
32.77 years
STANDARD_DEVIATION 10.09
Body Mass Index18.41 Kg/m²
STANDARD_DEVIATION 3.1
18.57 Kg/m²
STANDARD_DEVIATION 3.26
18.49 Kg/m²
STANDARD_DEVIATION 3.17
Education
Bachelor
4 Participants5 Participants9 Participants
Education
Elementary School
26 Participants27 Participants53 Participants
Education
High school
23 Participants24 Participants47 Participants
Education
Middle School
12 Participants8 Participants20 Participants
Income (million rupiahs)
Between one to three
26 Participants27 Participants53 Participants
Income (million rupiahs)
Less than one
38 Participants37 Participants75 Participants
Income (million rupiahs)
More than three
1 Participants0 Participants1 Participants
Occupation
Part timer
5 Participants3 Participants8 Participants
Occupation
Private
41 Participants39 Participants80 Participants
Occupation
Unemployed
19 Participants22 Participants41 Participants
Race/Ethnicity, Customized
Javanese
32 Participants28 Participants60 Participants
Race/Ethnicity, Customized
Madurese
31 Participants34 Participants65 Participants
Race/Ethnicity, Customized
Others
2 Participants2 Participants4 Participants
Region of Enrollment
Indonesia
Others
0 Participants0 Participants0 Participants
Region of Enrollment
Indonesia
Surabaya, East Java
65 Participants64 Participants129 Participants
Sex: Female, Male
Female
30 Participants29 Participants59 Participants
Sex: Female, Male
Male
35 Participants35 Participants70 Participants
Sputum Smear
Negative
21 Participants20 Participants41 Participants
Sputum Smear
Positive
44 Participants44 Participants88 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 750 / 72
other
Total, other adverse events
1 / 750 / 72
serious
Total, serious adverse events
0 / 750 / 72

Outcome results

Primary

Change in Bodyweight on a Digital Weight Scale From Baseline at 2 Months

Change of body weight of the participants over the two months intervention period as measured on a kilograms scale. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Positive numbers represent increases and negative numbers represent decreases. A higher value score in change means a better outcome on nutritional status for the patients after the study.

Time frame: Baseline, 2 months

Population: All participants were assessed their body weight (kg) using an electronic weight scale before and after the study to determine its change.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Bodyweight on a Digital Weight Scale From Baseline at 2 Months2.80 KilogramStandard Deviation 2.33
ControlChange in Bodyweight on a Digital Weight Scale From Baseline at 2 Months1.44 KilogramStandard Deviation 2.42
Secondary

Change in Body Mass Index (BMI) From Baseline at 2 Months

The change in BMI was assessed by a digital weight scale and height scale (kg/m²). The formula for BMI is weight in kilograms divided by height in meters squared. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Higher scores reflected the better nutritional status results of the patients.

Time frame: Baseline, 2 months

Population: All participants were assessed before and after the study using a standard formula to determine the change of the body mass index (BMI).

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Body Mass Index (BMI) From Baseline at 2 Months1.13 Kg/m²Standard Deviation 0.93
ControlChange in Body Mass Index (BMI) From Baseline at 2 Months0.54 Kg/m²Standard Deviation 0.94
Secondary

Change in Distance on 6-minute Walk Test (6MWT) From Baseline at 2 Months

The change distance in meters scale as assessed by 6MWT according to American Thoracic Society (ATS) 2002 guidelines. The 6MWT was carried out on a track along the 30-meter corridor marked by two colored cones placed at both ends of the track alignment. The participants were asked using the standard instruction to walk at their self-selected pace back and forth between the cones as far as they could for 6 minutes. The distance taken by each participant was measured and then recorded. Instructions were given to every patient by reading a guideline with the same intonations to every patient before performing the test. The result of the 6MWT was expressed in meters. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Higher scores reflected better physical function outcomes.

Time frame: Baseline, 2 months

Population: Not all participants were analyzed before and after the study to measure the change in the distance. Only 64 participants from the intervention group and 63 participants from the control group contributed to data collection.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Distance on 6-minute Walk Test (6MWT) From Baseline at 2 Months49.67 MeterStandard Deviation 58.49
ControlChange in Distance on 6-minute Walk Test (6MWT) From Baseline at 2 Months25.75 MeterStandard Deviation 56.85
Secondary

Change in Hand-grip Strength on a Digital Dynamometer Scale From Baseline at 2 Months

The change of hand-grip strength of the participants over the two months intervention period was measured on a kilograms scale. The change was calculated from two-time points as the value at the later time point minus the value at the earlier time point. Positive numbers represent increases and negative numbers represent decreases. The higher scores reflected the better physical function outcomes of the patients.

Time frame: Baseline, 2 months

Population: All participants were measured from two-times points, before and after the study in order to analyze their change after 2 months of intervention. Higher values reflected better physical function results.

ArmMeasureValue (MEAN)Dispersion
InterventionChange in Hand-grip Strength on a Digital Dynamometer Scale From Baseline at 2 Months3.90 KilogramStandard Deviation 4.5
ControlChange in Hand-grip Strength on a Digital Dynamometer Scale From Baseline at 2 Months0.84 KilogramStandard Deviation 4.83
Other Pre-specified

Caloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.

The average calorie intake (in kcal/day) was assessed by the 24-hour dietary recall questionnaire and calculated by NutriSurvey software version 2005, with the country-specific food database for Indonesia.

Time frame: In the course of the 8 week intervention, two interviews were conducted; at the 2nd and 6th week.

Population: Not all participants were assessed their calorie intake, only 61 participants in the control arm and all participants from intervention contributed to the data collection.

ArmMeasureGroupValue (MEAN)Dispersion
InterventionCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.2nd week1980.10 Kcal/dayStandard Deviation 437.79
InterventionCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.6th week2227.98 Kcal/dayStandard Deviation 463.72
InterventionCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.Average2113.16 Kcal/dayStandard Deviation 429.41
ControlCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.2nd week1844.64 Kcal/dayStandard Deviation 592.13
ControlCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.6th week2059.27 Kcal/dayStandard Deviation 550.52
ControlCaloric Intake on 24-hour Dietary Recall Method at the 2nd and 6th.Average1972.12 Kcal/dayStandard Deviation 530.04
Other Pre-specified

Protein Intake on 24-hour Dietary Recall Method.

The average protein intake (in Gram/day) was assessed by the 24-hour dietary recall questionnaire and calculated using NutriSurvey software version 2005, with the country specific food database for Indonesia.

Time frame: In the course of the 8 week intervention, two interviews were conducted; at the 2nd and 6th week.

Population: Not all participants were assessed before and after the study, only 61 participants from the control group contributed to the data collection of the study.

ArmMeasureGroupValue (MEAN)Dispersion
InterventionProtein Intake on 24-hour Dietary Recall Method.2nd week77.34 Gram/dayStandard Deviation 27.98
InterventionProtein Intake on 24-hour Dietary Recall Method.6th week77.70 Gram/dayStandard Deviation 26.72
InterventionProtein Intake on 24-hour Dietary Recall Method.Average77.52 Gram/dayStandard Deviation 26.63
ControlProtein Intake on 24-hour Dietary Recall Method.2nd week69.49 Gram/dayStandard Deviation 22.81
ControlProtein Intake on 24-hour Dietary Recall Method.6th week73.35 Gram/dayStandard Deviation 24.37
ControlProtein Intake on 24-hour Dietary Recall Method.Average71.42 Gram/dayStandard Deviation 21.06

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026